Glenmark Life Sciences Q1 Results

  • BSE: 543322
  • NSE: GLS
  • ISIN: INE03Q201024
  • Sector: Biotechnology & Drugs
BSE
1,097.5548.65 (4.64%)
Volume13.13 K
Updated: Mon 25 Nov, 2024 | 15:29:08
NSE
1,092.6547.00 (4.49%)
Volume2.00 L
Updated: Mon 25 Nov, 2024 | 15:42:42
Today: 1,024.70
1,108.15
52-Wk: 620.05
1,335.00

Q1 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Glenmark Life Sciences Q1 Results

    *All figures in crores except per share values
    Fiscal PeriodJun 24Mar 24QoQ CompJun 23YoY Comp
    Total Revenue 588.62536.60-%578.45-%
    Selling/ General/ Admin Expenses Total 56.8472.26-%48.13-%
    Depreciation/ Amortization 14.3914.53-%12.61-%
    Other Operating Expenses Total 84.5084.20-%89.12-%
    Total Operating Expense 443.52409.69-%397.90-%
    Operating Income 145.10126.91-%180.55-%
    Net Income Before Taxes 150.24129.68-%182.00-%
    Net Income 111.4897.94-%135.45-%
    Diluted Normalized EPS 9.087.97-%11.05-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts